The publication of "Percutaneous Liver Biopsy and Chronic Liver Disease in Haemophiliacs" in The Lancet meant that clinicians could no longer rely on the absence of overt or acute signs of hepatitis as a reliable indicator that non-A non-B Hepatitis would not develop.